{"article": [{"url": "https://www.marketwatch.com/story/moderna-inc-stock-outperforms-competitors-despite-losses-on-the-day-01602015931", "published": 1602002000.0, "headline": "Moderna Inc. stock outperforms competitors despite losses on the day", "body": "Shares of Moderna Inc. MRNA, +0.09% shed 1.26% to $71.04 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP, +1.39% falling 1.57% to 11,154.60 and Dow Jones Industrial Average DJIA, +0.56% falling 1.34% to 27,772.76. Moderna Inc. closed $24.17 short of its 52-week high ($95.21), which the company reached on July 17th. Despite its losses, the stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV, +0.41% fell 2.32% to $85.89 and Amgen Inc. AMGN, -1.41% fell 1.30% to $252.69. Trading volume (7.2 M) remained 4.8 million below its 50-day average volume of 12.1 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}